Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Prepaid Assets (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Prepaid Assets readings, the most recent being $5.2 million for Q4 2025.

  • Quarterly Prepaid Assets rose 32.12% to $5.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, up 32.12% year-over-year, with the annual reading at $5.2 million for FY2025, 32.12% up from the prior year.
  • Prepaid Assets hit $5.2 million in Q4 2025 for Terns Pharmaceuticals, up from $4.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.2 million in Q1 2024 and bottomed at $948000.0 in Q4 2021.
  • Average Prepaid Assets over 5 years is $3.3 million, with a median of $3.4 million recorded in 2022.
  • The largest annual shift saw Prepaid Assets surged 145.14% in 2024 before it crashed 33.52% in 2025.
  • Terns Pharmaceuticals' Prepaid Assets stood at $948000.0 in 2021, then surged by 118.46% to $2.1 million in 2022, then skyrocketed by 92.76% to $4.0 million in 2023, then fell by 1.18% to $3.9 million in 2024, then soared by 32.12% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for TERN's Prepaid Assets are $5.2 million (Q4 2025), $4.7 million (Q3 2025), and $3.5 million (Q2 2025).